BIO-Europe Spring: Partnering, China, and Mozart
Missed BIO-Europe Spring this week? Here are some of the participants' key takeaways and highlights from the event.
Missed BIO-Europe Spring this week? Here are some of the participants' key takeaways and highlights from the event.
Genentech's Tecentriq, alongside chemotherapy, becomes the first new treatment option for extensive-stage small cell lung cancer in 20 years.
GE Healthcare partners with Rockwell to improve bioprocessing automation operations, which could reduce review time of batch files and processes by weeks.
Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.
Fujifilm Irvine Scientific announces low hydrolysate medium for use in insect cell expression systems.
Thermo Fisher’s $1.7bn acquisition bolsters its ‘already strong position’ in the cell and gene therapy market, with increased CDMO capabilities.